Your browser doesn't support javascript.
loading
Dose-limiting, adverse event-associated bradycardia with ß-blocker treatment of atrial fibrillation in the GENETIC-AF trial.
Abraham, William T; Piccini, Jonathan P; Dufton, Christopher; Carroll, Ian A; Healey, Jeffrey S; O'Connor, Christopher M; Marshall, Debra; Aleong, Ryan; van Veldhuisen, Dirk J; Rienstra, Michiel; Wilton, Stephen B; White, Michel; Sauer, William H; Anand, Inder S; Huebler, Sophia P; Connolly, Stuart J; Bristow, Michael R.
Affiliation
  • Abraham WT; Ohio State University Medical Center, Columbus, Ohio.
  • Piccini JP; Duke Clinical Research Institute and Duke University Medical Center, Durham, North Carolina.
  • Dufton C; ARCA biopharma, Inc, Westminster, Colorado.
  • Carroll IA; ARCA biopharma, Inc, Westminster, Colorado.
  • Healey JS; Population Health Research Institute, McMaster University, Hamilton, California.
  • O'Connor CM; Inova Heart and Vascular Institute, Fairfax, Virginia.
  • Marshall D; ARCA biopharma, Inc, Westminster, Colorado.
  • Aleong R; University of Colorado Anschutz Medical Campus Division of Cardiology, Aurora, Colorado.
  • van Veldhuisen DJ; University of Groningen, University Medical Center, Groningen, the Netherlands.
  • Rienstra M; University of Groningen, University Medical Center, Groningen, the Netherlands.
  • Wilton SB; Libin Cardiovascular Institute of Alberta, University of Calgary, Calgary, Canada.
  • White M; Montreal Heart Institute, Montreal, Canada.
  • Sauer WH; Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
  • Anand IS; University of Minnesota, Minneapolis, Minnesota.
  • Huebler SP; ARCA biopharma, Inc, Westminster, Colorado.
  • Connolly SJ; Population Health Research Institute, McMaster University, Hamilton, California.
  • Bristow MR; ARCA biopharma, Inc, Westminster, Colorado.
Heart Rhythm O2 ; 3(1): 40-49, 2022 Feb.
Article in En | MEDLINE | ID: mdl-35243434

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials / Risk_factors_studies Language: En Journal: Heart Rhythm O2 Year: 2022 Document type: Article Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials / Risk_factors_studies Language: En Journal: Heart Rhythm O2 Year: 2022 Document type: Article Country of publication: